Salem, WI, United States of America

David A DeGoey

USPTO Granted Patents = 36 

 

Average Co-Inventor Count = 11.6

ph-index = 7

Forward Citations = 221(Granted Patents)


Company Filing History:


Years Active: 2010-2018

Loading Chart...
Loading Chart...
36 patents (USPTO):

Title: David A DeGoey: Innovator in Anti-Viral Compounds

Introduction

David A DeGoey, based in Salem, WI, is a prolific inventor with a commendable portfolio of 36 patents. His contributions particularly focus on the development of anti-viral compounds aimed at combating Hepatitis C virus (HCV) infections. His innovative work reflects a deep commitment to advancing medical science and improving public health through targeted therapeutic solutions.

Latest Patents

DeGoey's latest patents include breakthroughs in anti-viral compounds. His first notable invention features compounds specifically effective in inhibiting the activity of HCV polymerase, a crucial enzyme for the virus's replication. This patent encompasses not only the compounds themselves but also the processes and methods for creating these alternatives. Furthermore, he has developed additional compounds that are effective in hindering the replication of HCV, which again involves detailed processes for their production and usage in treating HCV infections. These advancements highlight his ongoing dedication to addressing significant health challenges associated with viral infections.

Career Highlights

Throughout his career, DeGoey has made impactful contributions while working with leading companies in the pharmaceutical industry, including AbbVie Inc. and Abbott Laboratories Corporation. His tenure at these organizations has allowed him to collaborate on various projects that hone in on the development of innovative therapeutic solutions. His expertise in medicinal chemistry and pharmacology has made a significant difference in the realm of viral infection treatment.

Collaborations

In addition to his individual accomplishments, DeGoey has collaborated with esteemed professionals in the industry, including Allan C Krueger and John T Randolph. These partnerships have likely fostered knowledge exchange and enhanced innovation, leading to the successful development of effective anti-viral solutions that can potentially save lives.

Conclusion

David A DeGoey stands out as a leading inventor in the pharmaceutical field, with a strong focus on anti-viral compounds for treating Hepatitis C virus infections. His extensive patent portfolio not only demonstrates his innovative spirit but also reflects the collaborative nature of modern scientific research. As he continues to push the boundaries of medicinal chemistry, his contributions serve as an inspiration for aspiring inventors and researchers committed to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…